# Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients

> **NCT01990118** · PHASE4 · COMPLETED · sponsor: **Penang Hospital, Malaysia** · enrollment: 106 (actual)

## Conditions studied

- End Stage Renal Failure

## Interventions

- **DRUG:** Neoral
- **DRUG:** Gengraf® capsule containing 25mg or 100mg cyclosporine

## Key facts

- **NCT ID:** NCT01990118
- **Lead sponsor:** Penang Hospital, Malaysia
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2005-12
- **Final completion:** 2006-05
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2013-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01990118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01990118, "Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01990118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*